|Day's Range||0.174 - 0.177|
|52 Week Range||0.110 - 0.400|
|PE Ratio (TTM)||5.71|
|Earnings Date||Jun 13, 2017 - Jun 19, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
NORTHVALE, N.J., May 25, 2017-- Elite Pharmaceuticals, Inc., today announced that top-line results for its reformulated SequestOx™ study are expected in July 2017. Patient disqualification and subsequesnt ...
NORTHVALE, N.J., May 22, 2017-- Elite Pharmaceuticals, Inc., today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application for Trimipramine Maleate Capsules 25, ...
NORTHVALE, N.J., April 04, 2017-- Elite Pharmaceuticals, Inc. today announced that it had filed an Abbreviated New Drug Application with the US Food and Drug Administration for a generic version of a synthetic ...